REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
13.16
+0.18 (1.39%)
At close: Dec 5, 2025, 4:00 PM EST
12.90
-0.26 (-1.98%)
After-hours: Dec 5, 2025, 7:56 PM EST
REGENXBIO Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for REGENXBIO stock ranges from a low of $12 to a high of $52. The average analyst price target of $30.29 forecasts a 130.17% increase in the stock price over the next year.
Price Target: $30.29 (+130.17%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for REGENXBIO stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $52 | Strong Buy | Maintains | $52 | +295.14% | Nov 20, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $17 → $19 | Buy | Maintains | $17 → $19 | +44.38% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +158.36% | Oct 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $34 | Strong Buy | Reiterates | $34 | +158.36% | Sep 8, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $52 | Strong Buy | Maintains | $52 | +295.14% | Sep 8, 2025 |
Financial Forecast
Revenue This Year
193.99M
from 83.33M
Increased by 132.80%
Revenue Next Year
288.01M
from 193.99M
Increased by 48.47%
EPS This Year
-3.09
from -4.59
EPS Next Year
-2.76
from -3.09
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 325.6M | 428.0M | ||||
| Avg | 194.0M | 288.0M | ||||
| Low | 156.9M | 137.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 290.8% | 120.6% | ||||
| Avg | 132.8% | 48.5% | ||||
| Low | 88.3% | -29.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.66 | -0.26 | ||||
| Avg | -3.09 | -2.76 | ||||
| Low | -4.03 | -5.12 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.